Showing results (231-240 of 682) with videos related to
Sort By:
Pageof 69
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1993
Platelet adhesion to fibrin(ogen)S C Endenburg, R R Hantgan, J J Sixma, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1996
Plasma fibrinogen inhibits platelets adhesion in flowing blood to immobilized fibrinogenS C Endenburg, L Lindeboom-Blokzijl, J J Zwaginga, et al.Seminars in Thrombosis and Hemostasis|September 10, 2009
The impact of the fibrinolytic system on the risk of venous and arterial thrombosisMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.The Lancet. Neurology|September 29, 2009
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control studyRolf T Urbanus, Bob Siegerink, Mark Roest, et al.Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1991
Validation of spontaneous morphine withdrawal symptoms in ratsJ W van der Laan, C J van 't Land, J G Loeber, et al.The Journal of Clinical Investigation|July 1, 1993
Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteinsF R Agbanyo, J J Sixma, P G de Groot, et al.The Journal of Laboratory and Clinical Medicine|October 1, 1983
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified componentsK S Sakariassen, P A Aarts, P G de Groot, et al.Thrombosis and Haemostasis|December 8, 1998
The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodiesD A Horbach, E van Oort, M J Tempelman, et al.Lupus|November 14, 1998
Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulantP G de Groot, D A Horbach, M J Simmelink, et al.Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'R T Urbanus, M T T Pennings, R H W M Derksen, et al.Pageof 69